Hain Lifescience GmbH is medium-sized company based in Nehren, in the district of Tübingen. The company was founded by the brothers David and Tobias Hain in 1986 and develops, manufactures and distributes molecular genetic diagnostic test systems and instruments for laboratories worldwide. With these tests systems definite statements can be made, for example about the presence of hereditary diseases or pathogenic bacteria which can cause serious diseases such as tuberculosis or hospital-acquired infections. More than 100 employees work at the headquarter in Nehren. Furthermore, the company has subsidiaries in Spain, United Kingdom, France, South Africa and Kenya as well as a global distribution network. Hain Lifescience has a certified quality management according to ISO 9001 and ISO 13485 and fulfills the European in-vitro diagnostics guidelines (98/79/EG). The world health organization (WHO) released several recommendations for Hain Lifescience products; most recently in May 2016 for the tuberculosis rapid test GenoType MTBDRsl.